Sign In
Buy INSM
$103.86
+0.130 (+0.125%)
At Close: Jun 03, 2026
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that final results from the Phase
Foresite Capital Management IV LLC Has $10.87 Million Stock Holdings in Insmed Incorporated (NASDAQ:INSM)
06:22am, Wednesday, 24'th Jun 2020
Foresite Capital Management IV LLC reduced its stake in shares of Insmed Incorporated (NASDAQ:INSM) by 52.5% in the first quarter, according to its most recent filing with the SEC. The institutional i
NI woman opens up about CF battle and helping others after surviving ICU
07:28pm, Sunday, 21'st Jun 2020
The Newtownabbey woman is giving something back with new clothing brand '65 roses'
Is Insmed Incorporated (INSM) Going to Burn These Hedge Funds?
03:58pm, Friday, 19'th Jun 2020
In this article we will take a look at whether hedge funds think Insmed Incorporated (NASDAQ:INSM) is a good investment right now. We check hedge fund and billionaire investor sentiment before delving
Results of a consensus meeting of clinical experts investigating sphingotec's diagnostic solutions for acute and critical care in COVID-19. sphingotec's biomarkers penKid, bio-ADM, and DPP3
Insmed Receives FDA Breakthrough Therapy Designation for Brensocatib in Patients with Non-Cystic Fibrosis Bronchiectasis (NCFBE)
12:00pm, Monday, 08'th Jun 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that the U.S. Food and Drug Admini
Edited Transcript of INSM earnings conference call or presentation 30-Apr-20 12:30pm GMT
08:53pm, Saturday, 06'th Jun 2020
Q1 2020 Insmed Inc Earnings Call
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12:00pm, Friday, 05'th Jun 2020
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards
Insmed to Present at Two June Conferences
12:00pm, Tuesday, 26'th May 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that Will Lewis, Chairman and Chie
A Look At The Intrinsic Value Of OSI Systems, Inc. (NASDAQ:OSIS)
05:15pm, Monday, 25'th May 2020
In this article we are going to estimate the intrinsic value of OSI Systems, Inc. (NASDAQ:OSIS) by taking the expected...
Insmed to Showcase New Brensocatib Data at American Thoracic Society Virtual Clinical Trials Session
01:29pm, Wednesday, 20'th May 2020
Insmed Incorporated (Nasdaq:INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced that new data from the Phase 2 WIL
Billionaire Steven Cohen Bets Big on These 3 Stocks
01:47pm, Tuesday, 19'th May 2020
And they’re off to the races. All three of the major U.S. stock indexes popped on Monday after biotech company Moderna reported its experimental COVID-19 vaccine produced encouraging results in its
Insmed Announces Closing of Public Offering of Common Stock and Full Exercise of Underwriters' Option to Purchase Additional Shares
02:46pm, Thursday, 07'th May 2020
Insmed Incorporated (Nasdaq: INSM) announced today the closing of the previously announced public offering of 11,155,000 shares of its common stock, including 1,455,000 shares issued pursuant to the e
Insmed Reports Inducement Grants Under NASDAQ Listing Rule 5635(c)(4)
12:00pm, Thursday, 07'th May 2020
Insmed Incorporated (Nasdaq: INSM), a global biopharmaceutical company on a mission to transform the lives of patients with serious and rare diseases, today announced the granting of inducement awards
Here's a roundup of top developments in the biotech space over the last 24 hours:Scaling The Peaks (Biotech stocks hitting 52-week highs May 5.) * Arcturus Therapeutics Ltd (NASDAQ: ARCT) (announced
